GlassScriptPhysician profile
Suzanne Brinson
NPI 1083346381
$2,825.46
in general payments reported to CMS, 2019-2025
28 companies · $534 in 2025
The $534 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,384 · 2024: $907 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $856.08 | 2023-2025 | |
| Lilly USA, LLC | $278.23 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Smith+Nephew, INC. | $249.87 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Glaxosmithkline, LLC. | $220.27 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Sanara Medtech INC. | $174.13 | 2025 | Celleraterx |
| Novo Nordisk INC | $133.53 | 2023-2024 | Rybelsus, Ozempic, Tresiba |
| Corium, LLC | $133.20 | 2023 | Azstarys |
| Amgen INC. | $97.79 | 2023-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $83.98 | 2023-2024 | Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $76.13 | 2023-2024 | Xarelto |
| Exact Sciences Corporation | $66.90 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $54.20 | 2023 | |
| Alexion Pharmaceuticals, INC. | $38.78 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $35.36 | 2025 | Iovera |
| Eisai INC. | $34.16 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $31.69 | 2023 | Sertraline Hcl, Gralise, Loreev Xr |
| Axsome Therapeutics, INC. | $31.65 | 2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $29.46 | 2024 | Rexulti |
| Edwards Lifesciences Corporation | $23.95 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Hologic Sales and Service, LLC | $22.54 | 2024 | Aptima |
| Orthofix Medical, INC. | $22.47 | 2025 | Physio-Stim |
| Regeneron Healthcare Solutions, INC. | $22.34 | 2023 | Evkeeza |
| Merck Sharp & Dohme LLC | $20.83 | 2023 | Gardasil 9 |
| Radius Health, INC. | $19.50 | 2024 | Tymlos |
| Boston Scientific Corporation | $19.45 | 2023 | |
| Esperion Therapeutics, INC. | $18.28 | 2023 | Nexletol |
| Kyowa Kirin, INC. | $16.53 | 2023 | Crysvita |
| Currax Pharmaceuticals LLC | $14.16 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Brinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.